BOIRON SA (BOI.PA) Stock Fundamental Analysis

EPA:BOI • FR0000061129

28.5 EUR
-1.35 (-4.52%)
Last: Feb 16, 2026, 07:00 PM
Fundamental Rating

5

Taking everything into account, BOI scores 5 out of 10 in our fundamental rating. BOI was compared to 52 industry peers in the Pharmaceuticals industry. BOI has an excellent financial health rating, but there are some minor concerns on its profitability. BOI has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year BOI was profitable.
  • BOI had a positive operating cash flow in the past year.
  • In the past 5 years BOI has always been profitable.
  • BOI had a positive operating cash flow in each of the past 5 years.
BOI.PA Yearly Net Income VS EBIT VS OCF VS FCFBOI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.45%, BOI is doing worse than 61.54% of the companies in the same industry.
  • BOI's Return On Equity of 5.25% is in line compared to the rest of the industry. BOI outperforms 40.38% of its industry peers.
  • BOI has a Return On Invested Capital of 4.43%. This is comparable to the rest of the industry: BOI outperforms 40.38% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BOI is significantly below the industry average of 14.38%.
Industry RankSector Rank
ROA 3.45%
ROE 5.25%
ROIC 4.43%
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
BOI.PA Yearly ROA, ROE, ROICBOI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • BOI's Profit Margin of 3.84% is in line compared to the rest of the industry. BOI outperforms 40.38% of its industry peers.
  • In the last couple of years the Profit Margin of BOI has declined.
  • BOI's Operating Margin of 5.26% is on the low side compared to the rest of the industry. BOI is outperformed by 61.54% of its industry peers.
  • In the last couple of years the Operating Margin of BOI has declined.
  • BOI has a better Gross Margin (73.71%) than 67.31% of its industry peers.
  • In the last couple of years the Gross Margin of BOI has remained more or less at the same level.
Industry RankSector Rank
OM 5.26%
PM (TTM) 3.84%
GM 73.71%
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
BOI.PA Yearly Profit, Operating, Gross MarginsBOI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BOI is destroying value.
  • The number of shares outstanding for BOI remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for BOI has been reduced compared to 5 years ago.
  • The debt/assets ratio for BOI is higher compared to a year ago.
BOI.PA Yearly Shares OutstandingBOI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BOI.PA Yearly Total Debt VS Total AssetsBOI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • BOI has an Altman-Z score of 3.76. This indicates that BOI is financially healthy and has little risk of bankruptcy at the moment.
  • BOI has a Altman-Z score (3.76) which is in line with its industry peers.
  • BOI has a debt to FCF ratio of 0.49. This is a very positive value and a sign of high solvency as it would only need 0.49 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.49, BOI belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
  • BOI has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
  • BOI's Debt to Equity ratio of 0.04 is amongst the best of the industry. BOI outperforms 88.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.49
Altman-Z 3.76
ROIC/WACC0.54
WACC8.13%
BOI.PA Yearly LT Debt VS Equity VS FCFBOI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 2.39 indicates that BOI has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.39, BOI is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • BOI has a Quick Ratio of 1.46. This is a normal value and indicates that BOI is financially healthy and should not expect problems in meeting its short term obligations.
  • BOI has a Quick ratio of 1.46. This is in the better half of the industry: BOI outperforms 76.92% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.46
BOI.PA Yearly Current Assets VS Current LiabilitesBOI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

  • BOI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.09%.
  • BOI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.40% yearly.
  • The Revenue has been growing slightly by 4.80% in the past year.
  • Measured over the past years, BOI shows a decrease in Revenue. The Revenue has been decreasing by -2.63% on average per year.
EPS 1Y (TTM)-18.09%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%241.06%
Revenue 1Y (TTM)4.8%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%7.58%

3.2 Future

  • The Earnings Per Share is expected to grow by 2.73% on average over the next years.
  • BOI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.54% yearly.
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BOI.PA Yearly Revenue VS EstimatesBOI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
BOI.PA Yearly EPS VS EstimatesBOI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 25.45, which means the current valuation is very expensive for BOI.
  • BOI's Price/Earnings is on the same level as the industry average.
  • BOI is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 12.32, the valuation of BOI can be described as correct.
  • Based on the Price/Forward Earnings ratio, BOI is valued a bit cheaper than 78.85% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, BOI is valued rather cheaply.
Industry RankSector Rank
PE 25.45
Fwd PE 12.32
BOI.PA Price Earnings VS Forward Price EarningsBOI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • BOI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BOI is cheaper than 94.23% of the companies in the same industry.
  • BOI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BOI is cheaper than 82.69% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.41
EV/EBITDA 6.54
BOI.PA Per share dataBOI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BOI does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.6
PEG (5Y)N/A
EPS Next 2Y2.73%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

  • BOI has a Yearly Dividend Yield of 4.07%, which is a nice return.
  • Compared to an average industry Dividend Yield of 1.89, BOI pays a better dividend. On top of this BOI pays more dividend than 82.69% of the companies listed in the same industry.
  • BOI's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.07%

5.2 History

  • The dividend of BOI decreases each year by -1.41%.
Dividend Growth(5Y)-1.41%
Div Incr Years0
Div Non Decr Years0
BOI.PA Yearly Dividends per shareBOI.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

5.3 Sustainability

  • BOI pays out 107.57% of its income as dividend. This is not a sustainable payout ratio.
DP107.57%
EPS Next 2Y2.73%
EPS Next 3YN/A
BOI.PA Yearly Income VS Free CF VS DividendBOI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BOI.PA Dividend Payout.BOI.PA Dividend Payout, showing the Payout Ratio.BOI.PA Dividend Payout.PayoutRetained Earnings

BOIRON SA

EPA:BOI (2/16/2026, 7:00:00 PM)

28.5

-1.35 (-4.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-06
Earnings (Next)04-02
Inst Owners5.63%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap500.18M
Revenue(TTM)504.86M
Net Income(TTM)19.37M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.07%
Yearly Dividend1.35
Dividend Growth(5Y)-1.41%
DP107.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 25.45
Fwd PE 12.32
P/S 0.99
P/FCF 13.41
P/OCF 9.45
P/B 1.36
P/tB 2
EV/EBITDA 6.54
EPS(TTM)1.12
EY3.93%
EPS(NY)2.31
Fwd EY8.12%
FCF(TTM)2.12
FCFY7.45%
OCF(TTM)3.02
OCFY10.58%
SpS28.77
BVpS21.03
TBVpS14.24
PEG (NY)4.6
PEG (5Y)N/A
Graham Number23.02
Profitability
Industry RankSector Rank
ROA 3.45%
ROE 5.25%
ROCE 5.9%
ROIC 4.43%
ROICexc 5.25%
ROICexgc 7.65%
OM 5.26%
PM (TTM) 3.84%
GM 73.71%
FCFM 7.39%
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
ROICexc(3y)8.01%
ROICexc(5y)8.34%
ROICexgc(3y)11.86%
ROICexgc(5y)12.41%
ROCE(3y)7.49%
ROCE(5y)7.29%
ROICexgc growth 3Y-33.41%
ROICexgc growth 5Y-24.37%
ROICexc growth 3Y-32.4%
ROICexc growth 5Y-24.82%
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.49
Debt/EBITDA 0.2
Cap/Depr 35.13%
Cap/Sales 3.1%
Interest Coverage 30.02
Cash Conversion 74.49%
Profit Quality 192.52%
Current Ratio 2.39
Quick Ratio 1.46
Altman-Z 3.76
F-Score7
WACC8.13%
ROIC/WACC0.54
Cap/Depr(3y)71.98%
Cap/Depr(5y)71.7%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.78%
Profit Quality(3y)124.88%
Profit Quality(5y)120.26%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.09%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%241.06%
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.8%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%7.58%
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%
EBIT growth 1Y-11.18%
EBIT growth 3Y-30.48%
EBIT growth 5Y-25.59%
EBIT Next Year86.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y113.74%
FCF growth 3Y22.31%
FCF growth 5Y12.1%
OCF growth 1Y57.85%
OCF growth 3Y5.87%
OCF growth 5Y-4.91%

BOIRON SA / BOI.PA FAQ

Can you provide the ChartMill fundamental rating for BOIRON SA?

ChartMill assigns a fundamental rating of 5 / 10 to BOI.PA.


What is the valuation status of BOIRON SA (BOI.PA) stock?

ChartMill assigns a valuation rating of 5 / 10 to BOIRON SA (BOI.PA). This can be considered as Fairly Valued.


How profitable is BOIRON SA (BOI.PA) stock?

BOIRON SA (BOI.PA) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for BOI stock?

The Price/Earnings (PE) ratio for BOIRON SA (BOI.PA) is 25.45 and the Price/Book (PB) ratio is 1.36.


Is the dividend of BOIRON SA sustainable?

The dividend rating of BOIRON SA (BOI.PA) is 5 / 10 and the dividend payout ratio is 107.57%.